NSECopy of Newspaper Publication1d ago · 29 Aug 2026, 06:50 pm
Copy of Newspaper Publication
Emcure Pharmaceuticals Limited · EMCURE
✦ AI Summary
Emcure Pharmaceuticals Limited has published a newspaper advertisement for its 45th Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The company has also provided details of remote e-voting facility for its members to cast their votes on the resolutions proposed to be passed at the AGM.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information
Attachments (1)
📄pdf
Download →
EMCURE_29082026184307_SE_IntimationNewspaperPublicationAGMnoticeandEvoting.pdf
View document text
Emcure
Ref: EPL/CS/SE/0077/2026 Date: August 29, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400 051 Mumbai- 400 001
Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Newspaper Advertisement of Notice of the
45th Annual General Meeting and e-voting Information.
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations
and Disclosures Requirements) Regulation, 2015, please find enclosed herewith copies of
newspaper advertisement published in “Financial Express”- all editions (English) and “Loksatta”-
Pune edition (Marathi) today i.e. on Saturday, August 29, 2026, which includes the following
information:
1. Intimation of 45th Annual General Meeting (“AGM”) of our Company to be held on
Monday, September 21, 2026, at 11.00 a.m. (IST) through Video Conferencing (“VC”) / other
audio-visual means (“OAVM”)
2. Details of remote e-voting facility provided to the Members of the Company, to enable them
to cast their votes on the resolutions proposed to be passed at the AGM.
This intimation is also available on the website of the Company: www.emcure.com.
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
Amruta Yangalwar
Company Secretary & Compliance Officer
ICSI Membership Number: A25687
Encl: As above
Emcure Pharmaceuticals Limited
Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India
Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251